Who Owns Swedencare Company?

Swedencare Bundle

Get Full Bundle:

	SWOT	$15	$10
	5 FORCES	$15	$10
	BCG	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10

TOTAL:

ADD TO CART

Who Really Owns Swedencare?

Ever wondered who's steering the ship at Swedencare, a rising star in the pet healthcare industry? Understanding the Swedencare SWOT Analysis is just the beginning. Knowing the ownership structure of a company like Swedencare is key to grasping its strategic direction and its potential for growth. This deep dive reveals the key players behind the scenes.

From its humble beginnings in 2000, founded by Dr. Sune Wikner and Roland Fastberg, Swedencare has transformed into a global force, currently valued at $736 million as of June 12, 2025. This exploration of the Swedencare ownership will uncover the influence of Swedencare investors, the role of Swedencare management, and the impact of public shareholders on the Swedencare company's trajectory. Learn more about the Swedencare AB ownership structure and how to buy Swedencare stock.

The story of Swedencare begins in 2000, founded by Dr. Sune Wikner, a Swedish dentist, and his colleague Roland Fastberg. Their partnership was built upon Dr. Wikner's earlier discovery in the 1970s of a specific type of seaweed. This seaweed showed promising results in improving oral health, a finding later validated in the 1990s with a dog whose dental health improved after the addition of the seaweed to its diet.

The initial focus of the Swedencare company was the ProDen PlaqueOff® product line, specifically targeting dental health for pets. While the exact initial ownership structure, including shareholding percentages for Dr. Wikner and Roland Fastberg, is not publicly available, their roles were fundamental in establishing the company and its first product offerings. This early phase set the stage for the company's future growth and development in the pet health sector.

The evolution of Swedencare ownership is a key part of its history. In 2014, the founders made a significant decision to sell the company, which marked a pivotal moment. This transition brought in new leadership, including Håkan Lagerberg, Håkan Svanberg, and Johan Bergdahl. Håkan Lagerberg took on the role of CEO, while Håkan Svanberg and Johan Bergdahl joined the board. This change in ownership was accompanied by a new business plan. This new plan contributed to increased sales and improved profit margins.

Key Ownership Changes

The founders, Dr. Sune Wikner and Roland Fastberg, played a crucial role in the initial establishment of the Swedencare company. Their early work laid the foundation for the company's focus on pet dental health. The sale of the company in 2014 introduced new leadership and strategic direction, enhancing its market position. If you are interested in a deeper understanding of the competitive landscape, you can read more about it in the Competitors Landscape of Swedencare.

• The founders established the company in 2000.
• The company's initial focus was on the ProDen PlaqueOff® product line.
• The founders sold the company in 2014.
• New leadership, including Håkan Lagerberg, was introduced.

Swedencare SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

The evolution of Swedencare's ownership reflects its journey from a privately held entity to a publicly traded company. Initially, the company was under founder ownership. Key milestones include its listing on the Nasdaq First North Growth Market and later trading on the OTCQX® Best Market. This transition opened the door for a broader range of Swedencare investors and institutional participation, shaping its current ownership structure.

As of March 31, 2025, Swedencare had 158,862,839 outstanding shares, illustrating the scale of its public presence. This transition to public trading significantly altered the landscape of Swedencare ownership, with various institutional and individual investors now holding stakes in the company. The shift also brought increased scrutiny and transparency, influencing the company's strategic decisions and financial performance.

As of December 31, 2024, the Board of Directors collectively held shares representing 61.0% of the total outstanding shares. Håkan Lagerberg, the CEO since 2014, owns 3.6% through Mastan AB. Institutional investors also play a key role, with 17 institutional owners holding a total of 3,525,627 shares as of April 30, 2025. These details offer insights into the dynamics of Swedencare's major shareholders and their influence on the company.

Ownership Insights

Swedencare's ownership structure is diverse, with significant stakes held by both institutional investors and key individuals. The company's transition to a publicly traded entity has broadened its investor base, impacting its strategic direction.

• Symrise AG holds the largest share, at 41.1%.
• The Board of Directors collectively held 61.0% of the total outstanding shares as of December 31, 2024.
• Institutional investors have a substantial presence.
• Understanding the ownership is key to evaluating Swedencare's performance, as discussed in Growth Strategy of Swedencare.

Swedencare PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

As of April 25, 2025, the Board of Directors of the company consists of seven members. The re-elected members from the Annual General Meeting on April 25, 2024, include Håkan Svanberg, Johan Bergdahl, Thomas Eklund, Sara Brandt, Ulrika Valassi, and Jean-Yves Parisot. Isabelle Guiller was newly elected in 2025. Håkan Svanberg serves as the Chairman of the Board. This structure is crucial for understanding the company's governance and the distribution of power among its stakeholders, directly impacting decisions related to the company's strategic direction and financial performance.

The composition of the board reflects the company's ownership structure. Håkan Svanberg represents Håkan Svanberg & Co Health Care AB, Jean-Yves Parisot represents Symrise AG, and Johan Bergdahl represents JCC Group Invest Sweden AB on the Nomination Committee. These three largest shareholders as of September 30, 2024, have the right to appoint a member to the nomination committee. As of December 31, 2024, the Board of Directors collectively held 61.0% of the total outstanding shares, indicating significant control over the company's operations and strategic decisions. This concentration of ownership is a key factor for potential Swedencare investors to consider.

The company operates under a one-share-one-vote structure, ensuring that all shareholders listed in the share register can participate and vote according to their shareholdings. The Annual General Meeting, held within six months of the financial year-end, is the highest decision-making body. The Board has the authority to issue new shares, with or without preferential rights, up to a maximum of 17,760,106 shares, as authorized by the annual general meeting on April 25, 2024. In April 2025, 978,119 shares were issued to the seller of Summit Veterinary Pharmaceuticals Limited as part of the acquisition payment, resulting in a dilution of approximately 0.61%. This provides insight into Swedencare ownership and how management utilizes financial instruments.

Understanding Swedencare's Ownership

Understanding the ownership structure of the company is vital for investors. It influences decision-making and the strategic direction of the company. The board's composition and voting rights are key factors.

• Board members represent major shareholders.
• One-share-one-vote structure.
• Annual General Meeting is the highest decision-making body.
• The board can issue new shares.

Swedencare Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

Over the past few years, the Swedencare company has significantly reshaped its ownership structure through strategic acquisitions. These moves have not only expanded its product offerings but also influenced its investor base and market position. The company's acquisitions of NaturVet and Innovet in 2022, followed by Summit Veterinary Pharmaceuticals Limited in early 2025, demonstrate a clear strategy of growth and expansion within the animal health sector. The acquisition of Summit, finalized on April 1, 2025, involved a combination of cash and share issuance, with Steve Organ, the founder of Summit, becoming a Swedencare shareholder.

The acquisitions of MedVant Inc. in 2024 and Riley's® Organics in January 2024 also played a role in the evolution of Swedencare's ownership. These deals, which included share issuances to the sellers, further diversified the shareholder base. The establishment of the Treats product group, following the Riley's® Organics acquisition, showed a remarkable 90% growth in the first quarter of 2025. As of December 31, 2024, the company had 9,492 shareholders, reflecting a broad investor base. These changes highlight the dynamic nature of Swedencare ownership and its commitment to strategic growth.

The Annual General Meeting on April 25, 2025, approved a dividend of SEK 0.25 per share for the financial year 2024, payable on May 2, 2025. Swedencare management aims to reach revenues of SEK 4 billion by 2026 with an EBITDA-margin exceeding 30%, primarily through organic growth. Despite an increase in institutional ownership and insider buying in recent months, the Swedencare stock price as of April 30, 2025, was 38.60 SEK per share, a decrease of 31.50% from May 2, 2024. For more details on Swedencare's strategic moves, consider reading about the Growth Strategy of Swedencare.

Who Owns Swedencare?

Swedencare's ownership is a mix of institutional and individual shareholders. Recent acquisitions have led to changes in the shareholder base.

Acquisition Impact

Acquisitions like Summit and MedVant have involved share issuances, changing the ownership structure. The founder of Summit became a shareholder.

Dividend and Financial Goals

A dividend of SEK 0.25 per share was approved for 2024. The company aims for SEK 4 billion in revenue by 2026.

Stock Performance

The stock price as of April 30, 2025, was 38.60 SEK, down 31.50% from May 2, 2024, despite insider confidence.

Swedencare Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔

Related Blogs